NSE · ZIMLAB
Zim Laboratories Limited (ZIMLAB) Share Price
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,722
of 5,047 stocks
▲ 251W▼ 201M
Peak #1,670 · 11 Oct 2026
Zim Laboratories Limited, a smallcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, has a subdued return on equity, and is seeing revenue slip.
Market Cap
750.52 Cr
P/E Ratio
117.54
P/B Ratio
2.53
ROE
1.97%
ROCE
6.14%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q2 2026-27 | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 |
|---|---|---|---|---|
| Revenue | 105.45 Cr | 94.18 Cr | 105.27 Cr | 108.66 Cr |
| Net Profit | -2.05 Cr | -4.02 Cr | 3.74 Cr | 4.40 Cr |
| EPS | -0.38 | -0.75 | 0.76 | 0.90 |
| Operating Profit | 1.20 Cr | -1.93 Cr | 8.25 Cr | 9.48 Cr |
Shareholding pattern
Promoter
30.36%
Public
69.64%
PUBLIC BREAKDOWN
DII
0.07%
Individuals
34.71%
Mutual fund holdings
₹8.60
Cr total
1
Schemes
1
Fund Houses
₹8.60 Cr
Total Exposure
Tata Mutual Fund₹8.60 Cr (100.0%)
| Scheme | Fund House | Value (Cr) | % |
|---|
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 20 Jun 2024 | Other | Annual General Meeting |
| 03 Jul 2023 | Other | Annual General Meeting |
| 22 Dec 2022 | Bonus | Bonus 2:1 |
Other Healthcare stocks
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.